They're each "proven" for a relatively small (sometimes overlapping) subset of the population. If anything, psychopharmacology has taught us about the extreme variance in brain chemistries and how difficult the problem is when it comes to treatment. Adding more options is a great thing, as long as there is strong science behind it.